Shalini S Sharma NEW DELHI: On March 19, the pharmaceutical landscape in India didn’t just shift; it underwent a tectonic reorganisation. For years, the “miracle” weight-loss molecule, semaglutide, had been the exclusive playground of the wealthy — a luxury accessible only to those who could afford the steep Rs 10,000+ monthly price tag of the…
…
A platform for change and progress. At Blitz India Business, our vision is to be a transformative platform that elevates the role of business and industry in driving India’s journey towards Viksit Bharat 2047. We are dedicated to fostering innovation, championing sustainability, and promoting inclusivity, while building a bridge for collaboration and progress.
Quick Links
Get important news delivered directly to your inbox and stay connected!